Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+
NCT01220076
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Non Metastatic Breast Cancer
Interventions
DRUG:
tamoxifen
Sponsor
Institut Cancerologie de l'Ouest